K-numberK241626
Device nameSperSort™ Sperm Sorting Chip (IPG02)
ApplicantIpreg Incorporation
Product codeMQK
Device classClass II
Decision dateFeb 20, 2025
DecisionSubstantially Equivalent
Regulation884.6160
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

The SperSort™ Sperm Sorting Chip (IPG02) is a single-use, sterile device that separates motile sperm from semen samples for use in assisted reproductive procedures including ICSI, IVF, and IUI. The device uses a swim-up mechanism where liquefied semen is placed in a lower chamber and sperm washing medium in an upper chamber; motile sperm migrate through a porous filter over 30 minutes at 37°C for collection.

Technological characteristics

The device is made of polycarbonate (versus the predicate's polymethylmethacrylate, polycarbonate, and polyethylene fibers), has a 1.9 mL processing volume, a 2-year shelf-life (versus 12 months), and an endotoxin limit of ≤20 EU/device (versus ≤2.15 EU/device). Both devices use gamma irradiation sterilization to SAL 10⁻⁶ and are prescription-use, single-use products with identical indications and the same fundamental design of sample chamber, porous filter, and collection port.

Test standards cited

ISO 11137-1:2018 and 11137-2:2015 for sterilization validation; ASTM F1980-21 for shelf-life/accelerated aging; ASTM D4169-22 for simulated transportation; ASTM F1886/F1886M-16 for package visual inspection; ASTM F1929-23 for dye penetration; ASTM F88/F88M-23 for seal strength; USP<85> for endotoxin testing.

Substantial equivalence argument

The subject and predicate devices share the same indications for use and fundamental design principle (swim-up separation of motile sperm through a microporous membrane). Although they differ in materials, processing volume, shelf-life, and endotoxin specification, the submitter contends these differences do not raise different questions of safety and effectiveness because the core separation mechanism and clinical purpose are identical. Performance testing demonstrated the subject device achieves equivalent or superior sperm motility recovery (95.89% total motility, 92.97% progressive motility), and stability testing confirmed maintenance of performance over the stated shelf-life.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →